L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea flag South Korea · Delayed Price · Currency is KRW
69,700
+5,800 (9.08%)
Apr 10, 2026, 3:30 PM KST

L&C BIO Co.,LTD Revenue

In the year 2025, L&C BIO Co.,LTD had annual revenue of 85.48B KRW with 18.66% growth. L&C BIO Co.,LTD had revenue of 24.67B in the quarter ending December 31, 2025, with 29.00% growth.

Revenue
85.48B
Revenue Growth
+18.66%
P/S Ratio
18.58
Revenue / Employee
606.22M
Employees
141
Market Cap
1.59T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202585.48B13.44B18.66%
Dec 31, 202472.03B6.11B9.26%
Dec 31, 202365.93B13.35B25.40%
Dec 31, 202252.57B6.90B15.10%
Dec 31, 202145.68B12.70B38.53%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Seegene474.23B
i-SENS315.44B
InBody Co.,Ltd233.95B
WON TECH156.84B
Osang Healthcare Co.,Ltd128.63B
DRTECH116.30B
Bio Plus90.90B
Curexo74.53B
Revenue Rankings